Influence of Pyrolysis Temperature and Production Conditions on Switchgrass Biochar for Use as a Soil Amendment

Biochars form recalcitrant carbon and increase water and nutrient retention in soils; however, the magnitude is contingent upon production conditions and thermo-chemical conversion processes. Herein we aim at (i) characterizing switchgrass (Panicum virgatum L.)-biochar morphology, (ii) estimating water-holding capacity under increasing ratios of char: soil; and, (iii) determining nutrient profile variation as a function of pyrolysis conversion methodologies (i.e. continuous, auger pyrolysis system versus batch pyrolysis systems) for terminal use as a soil amendment. Auger system chars produced at 600 °C had the greatest lignin portion by weight among the biochars produced from the continuous system. On the other hand, a batch pyrolysis system (400 °C – 3h) yielded biochar with 73.10% lignin (12 fold increases), indicating higher recalcitrance, whereas lower production temperatures (400 °C) yielded greater hemicellulose (i.e. greater mineralization promoting substrate). Under both pyrolysis methods, increasing biochar soil application rates resulted in linear decreases in bulk density (g cm-3). Increases in auger-char (400 °C) applications increased soil water-holding capacities; however, application rates of \u3e2 Mt ha-1 are required. Pyrolysis batch chars did not influence water-holding abilities (P\u3e0.05). Biochar macro and micronutrients increased, as the pyrolysis temperature increased in the auger system from 400 to 600 °C, and the residence time increased in the batch pyrolysis system from 1 to 3 h. Conversely, nitrogen levels tended to decrease under the two previously mentioned conditions. Consequently, not all chars are inherently equal, in that varying operation systems, residence times, and production conditions greatly affect uses as a soil amendment and overall rate of efficacy

Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Transformation of Swine Manure and Algal Consortia to Value-added Products

The swine production sector is projected to grow globally. In the past, this growth manifested itself in increased herd sizes and geographically concentrated production. Although economically sound, these trends had negative consequences on surrounding ecosystems. Over-application of manure resulted in water quality degradation, while long-term storage of manure slurries was found to promote release of potent GHG emissions. There is a need for innovative approaches for swine manure management that are compatible with current scales of production, and increasingly strict environmental regulations. This study aims to investigate the potential for incorporating gasification as part of a novel swine manure management system which utilizes liquid-solid separation and periphytic algal consortia as a phycoremediation vector for the liquid slurry. The gasification of swine manure solids, and algal biomass solids generate both a gaseous fuel product (producer gas) in addition to a biochar co-product. First, the decomposition kinetics for both feedstock, i.e., swine manure solids, and algal solids, were quantified using thermogravimetry at different heating rates (1 ~ 40°C min-1) under different atmospheres (nitrogen, and air). Pyrolysis kinetics were determined for manure solids from two farms with different manure management systems. Similarly, the pyrolysis kinetics were determined for phycoremediation algae grown on swine manure slurries. Modeling algal solids pyrolysis as first-order independent parallel reactions was sufficient to describe sample devolatilization. Combustion of swine manure solids blended with algal solids, at different ratios, showed no synergistic effects. Gasification of phycoremediation algal biomass was studied using a bench-scale auger gasification system at temperatures between 760 and 960°C. The temperature profile suggested a stratification of reaction zones common to fixed-bed reactors. The producer gas heating value ranged between 2.2 MJ m-3 at 760°C, and 3.6 MJ m-3 at 960°C. Finally, life cycle assessment (LCA) was used to evaluate a proposed swine manure management system that includes a thermochemical conversion sub-system: drying, gasification, and producer-gas combustion (boiler). Liquid manure storage (uncovered tank) was the biggest contributor to GHG emissions. Liquid slurry management stages were credited with the highest fossil fuel use. Improvements to separation and drying technologies can improve this conversion scenario

Gasification of Phycoremediation Algal Biomass

Microalgae have been utilized in wastewater treatment strategies in various contexts. Uncontrolled algal species are a cheap and effective remediation strategy. This study investigates the thermochemical potential of wastewater treatment algae (phycoremediation) as a means to produce renewable fuel streams and bio-products. Three gasification temperature levels were investigated in an auger gasification platform: 760, 860, and 960 °C. Temperature increases resulted in corresponding increases in CO and H2 concentrations in the producer gas from 12.8% and 4.7% at 760 °C to 16.9% and 11.4% at 960 °C, respectively. Condensable yields ranged between 15.0% and 16.6%, whereas char yields fell between 46.0% and 51.0%. The high ash content (40% on a dry basis) was the main cause of the elevated char yields. On the other hand, the relatively high yields of condensables and a high carbon concentration in the char were attributed to the low conversion efficiency in this gasification platform. Combustion kinetics of the raw algae, in a thermogravimetric analyzer, showed three consecutive stages of weight loss: drying, devolatilization, and char oxidation. Increasing the algae gasification temperature led to increases in the temperature of peak char oxidation. Future studies will further investigate improvements to the performance of auger gasification

Opportunities and Barriers to Bioenergy Conversion Techniques and Their Potential Implementation on Swine Manure

The objectives of this article are to offer a comprehensive evaluation of the opportunities and barriers for swine manure conversion technologies and to shed light on the gaps that might require further investigation to improve the applicability of these technologies. The challenges of manure management have been propagated alongside the global growth of swine production. Various technologies that target the production of energy, fuels, and bioproducts from swine manure have been reported. These technologies include pretreatments, i.e., drying, and solid separation; biological techniques, i.e., composting, anaerobic digestion, and biodrying; and thermochemical techniques, i.e., combustion, gasification, pyrolysis, liquefaction, and carbonization. The review highlights the yields and qualities of products, i.e., energy, gaseous fuel, liquid fuel, and solid fuel, of each technology. It exhibits that the choice of a conversion technology predominantly depends on the feedstock properties, the specifics of the conversion technique, the market values of the end products as well as the local regulations. The challenges associated with the presented techniques are discussed to ameliorate research and development in these areas. The notable finding of this paper is that there is a need for full-scale research in the area of thermochemical conversion of solid-separated swine manure

Influence of Pyrolysis Temperature and Production Conditions on Switchgrass Biochar for Use as a Soil Amendment

Biochars form recalcitrant carbon and increase water and nutrient retention in soils; however, the magnitude is contingent upon production conditions and thermo-chemical conversion processes. Herein we aim at (i) characterizing switchgrass (Panicum virgatum L.)-biochar morphology, (ii) estimating water-holding capacity under increasing ratios of char: soil; and, (iii) determining nutrient profile variation as a function of pyrolysis conversion methodologies (i.e. continuous, auger pyrolysis system versus batch pyrolysis systems) for terminal use as a soil amendment. Auger system chars produced at 600°C had the greatest lignin portion by weight among the biochars produced from the continuous system. On the other hand, a batch pyrolysis system (400 °C – 3h) yielded biochar with 73.10% lignin (12 fold increases), indicating higher recalcitrance, whereas lower production temperatures (400 °C) yielded greater hemicellulose (i.e. greater mineralization promoting substrate). Under both pyrolysis methods, increasing biochar soil application rates resulted in linear decreases in bulk density (g cm-3). Increases in auger-char (400 °C) applications increased soil water-holding capacities; however, application rates of >2 Mt ha-1 are required. Pyrolysis batch chars did not influence water-holding abilities (P>0.05). Biochar macro and micronutrients increased, as the pyrolysis temperature increased in the auger system from 400 to 600 °C, and the residence time increased in the batch pyrolysis system from 1 to 3 h. Conversely, nitrogen levels tended to decrease under the two previously mentioned conditions. Consequently, not all chars are inherently equal, in that varying operation systems, residence times, and production conditions greatly affect uses as a soil amendment and overall rate of efficacy

The Natural History of Incidental Colonic Diverticulosis on Screening Colonoscopy

Background. The natural history of colonic diverticulosis is unclear. Methods. Patients with incidental diverticulosis identified in a previous prospective cross-sectional screening colonoscopy study were evaluated retrospectively for clinic or hospital visit(s) for diverticular disease (DD= acute diverticulitis or diverticular bleeding) using review of electronic health records and patient phone interview. Results. 826 patients were included in the screening colonoscopy study. Three were excluded for prior DD. In all, 224 patients (27.2%; mean age 62.3 ± 8.2) had incidental diverticulosis distributed in the left colon (67.4%), right colon (5.8%), or both (22.8%). Up-to-date information was available on 194 patients. Of those, 144 (74.2%) could be reached for detailed interview and constituted the study population. Over a mean follow-up of 7.0 ± 1.7 years, DD developed in 6 out of 144 patients (4.2%) (4 acute cases of diverticulitis, 1 probable case of diverticular bleeding, and 1 acute case of diverticulitis and diverticular bleeding). Two patients were hospitalized, and none required surgery. The time to event was 5.1 ± 1.6 years and the incidence rate was 5.9 per 1000 patient-years. On multivariate analysis, none of the variables collected at baseline colonoscopy including age, gender, obesity, exercise, fiber intake, alcohol use, constipation, or use of NSAIDs were associated with DD. Conclusion. The natural history of incidental diverticulosis on screening colonoscopy was highly favorable in this well-defined prospectively identified cohort. The common scenario of incidental diverticulosis at screening colonoscopy makes this information clinically relevant and valuable to physicians and patients alike